Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.

about

Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.

Item

http://www.wikidata.org/entity/Q47860273

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effects of intravenous home do ...... ization, and cost expenditure.

@en

Effects of intravenous home do ...... ization, and cost expenditure.

@nl

type

Item

label

Effects of intravenous home do ...... ization, and cost expenditure.

@en

Effects of intravenous home do ...... ization, and cost expenditure.

@nl

prefLabel

Effects of intravenous home do ...... ization, and cost expenditure.

@en

Effects of intravenous home do ...... ization, and cost expenditure.

@nl

P1476

Effects of intravenous home do ...... ization, and cost expenditure.

@en

P2093

Evert Luwel

http://www.w3.org/2001/XMLSchema#string

Herwig Van Aerde

http://www.w3.org/2001/XMLSchema#string

Jan Vercammen

http://www.w3.org/2001/XMLSchema#string

Linda Jacobs

http://www.w3.org/2001/XMLSchema#string

Matthias Dupont

http://www.w3.org/2001/XMLSchema#string

Monique Renaers

http://www.w3.org/2001/XMLSchema#string

Peter Potargent

http://www.w3.org/2001/XMLSchema#string

Pieter Martens

http://www.w3.org/2001/XMLSchema#string

Wendy Ceyssens

http://www.w3.org/2001/XMLSchema#string

Wilfried Mullens

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure

The REMATCH trial: rationale, design, and end points

Chronic inotropic therapy in end-stage heart failure.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society o

Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.

Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.

Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology.

Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting.

P31

scholarly article

P356

10.1002/EHF2.12248

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29341466

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

hospitalization

P932

6073033

http://www.w3.org/2001/XMLSchema#string